摘要Use of a composition comprising myo-inositol hexaphosphate corresponding to the formula: or pharmaceutically acceptable salts thereof for the manufacture of a medicament for the prevention and / or treatment by topical administration of a disease associated with the development of heterogeneous nucleants consisting in a pathological calcification in a soft tissue.
更多相关知识
- 浏览0
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



